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ABSTRACT
Effect of the NMDA Receptor Antagonist MK-801 on Recovery From
Spinal Cord Injury in Rats Given Uncontrollable Stimulation (April 2006)
Christine E. Petrich
Department of Psychology
Texas A&M University
Fellows Advisor: Dr. James. W. Grau
Department of Psychology
The eventual outcome of spinal cord injury is largely influenced by damage that occurs
after the injury. Damaged connections between spinal cord cells and the brain allow a
positive feedback mechanism to go unchecked when activated by ascending pain
messages. Over-excitation then causes secondary damage. This study examines whether
a pharmacological manipulation that should attenuate over-excitation reduces the
adverse effects of shock treatment. Rats received spinal impact injuries and, the next
day, were given the NMDA receptor antagonist MK-801 (0.08 mg/kg, i.p.) or its vehicle
before receiving either a bout of uncontrollable stimulation or identical treatment
without the stimulation itself. Their hindlimb motor activity was monitored for 21 days.
Results indicate a significant effect of the drug on rats that received uncontrollable
stimulation. The study has clinical implications for the treatment of spinal cord injuries
in humans.
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1INTRODUCTION1
Spinal cord injury can have devastating long-term consequences, including
intractable pain, paralysis, and loss of sensation, which disrupt the ability to function and
may cause feelings of despair. The last decade has brought increased hope in behavioral,
physiological, and pharmacological procedures to restore some function and reduce
injury-related pain. Spinal cord systems have been shown to have the plasticity needed
to reestablish neural connections and to adapt to new environmental and physiological
conditions (e.g., Barbeau, Ladouceur, Norman, Pepin, & Leroux, 1999; Carrier,
Brustein, & Rossignol, 1997; Cheng, Cao, & Olson, 1996; Edgerton, Roy, de Leon,
Tillakaratne, & Hodgson, 1997; Hodgson, Roy, de Leon, Dobkin, & Edgerton, 1994;
Hulsebosch, Hains, Waldrep, & Young, 2000; Wernig, Muller, Nanassy, & Cagol,
1995).
Several studies have provided evidence for spinal cord plasticity. After spinal
cord injury in either a cat or a human, behavioral training can reestablish stepping on a
treadmill, and the spinal circuitry that underlies stepping can “learn” or adapt to new
environmental relations (Carrier et al., 1997; Edgerton et al., 1997; Hodgson et al., 1994;
Rossignol, 1996; Wernig et al., 1995). On the other hand, plasticity can also have
negative effects. Neuropathic pain can arise when painful stimuli from injury or
inflammation sensitize neurons of the spinal cord, a phenomenon called central
                                                 
1 This thesis follows the style and format of Behavioral Neuroscience.
2sensitization (Coderre, 1993; Dickenson, 1996; Willis, Sluka, Rees, & Westlund, 1996;
Woolf, 1983, 1984).
In central sensitization, damage to descending modulatory tracts allows afferent
input to lead to glutamate over-excitation in the spinal cord and thus to enhance
secondary damage (Beattie, Farooqui, & Bresnahan, 2000). Because of this,
uncontrollable stimulation after spinal cord injury impairs recovery, as demonstrated by
Grau and colleagues (2004). In their study, spinally contused rats that received
uncontrollable legshock had poor recovery, with respect to locomotor ability, bladder
function, limb rigidity (spasticity), weight gain, and mortality, relative to both unshocked
rats and rats that received controllable (response-contingent) legshock. Rats that received
controllable shock exhibited normal recovery, indicating that lack of instrumental
control is crucial for the deleterious consequences of nociceptive stimulation.
Evidence suggests that the mechanisms for this sort of cellular memory are
similar to those that govern storage of information in the hippocampus (Ji, Kohno,
Moore, & Woolf, 2003; Willis, 2002). The hippocampus utilizes long-term potentiation,
which is mediated by NMDA receptors in concert with other molecules. Joynes, Janjua,
and Grau (2004) used a spinal transection model to demonstrate the importance of the
NMDA receptor in spinal cord learning. Rats’ spinal cords were transected (severed),
and an NMDA receptor antagonist or its vehicle was administered. Subjects then
received response-contingent shock. Vehicle-treated rats learned to keep their legs in a
flexed position, whereas the NMDA receptor antagonist inhibited learning.
3Learning to keep the leg in a flexed position can also be blocked by prior
exposure to noncontingent shock (Joynes & Grau, 2004). Ferguson and colleagues
(2006) went on to show that pretreatment with MK-801, a noncompetitive NMDA
receptor antagonist, can block this deficit. They suggest that uncontrollable shock blocks
subsequent learning because it saturates neural plasticity. Neural plasticity is the end
result of central sensitization, which diffusely enhances neural excitability within the
spinal cord. Therefore, along with the aforementioned damage associated with central
sensitization, it seems to also inhibit further spinal learning and, potentially, the repair of
spinal connections.
The present experiment therefore tested whether the NMDA receptor antagonist
MK-801 protects spinally contused subjects from the adverse effects of uncontrollable
stimulation.
4METHODS
Subjects
Subjects were 44 male Sprague-Dawley rats obtained from Harlan (Houston,
Texas), weighing 300–390 g. They were 90–110 days old and were housed individually
in Plexiglas bins (45.7 [length] x 23.5 [width] x 20.3 [height] cm). A 12/12 hr light/dark
cycle was maintained in their colony (8 a.m. on/8 p.m. off), and food and water were
available ad libitum. Extra bedding was added to each cage after surgery to facilitate
access to food and water. Additionally the short rat sipper tubes of water were replaced
with long mouse sipper tubes to allow for easy reaching without rearing. Subjects were
weighed regularly and checked daily for signs of spasticity and autophagia. Spasticity
was identified if a subject’s limb was fixed in an extended position and was resistant to
movement. Subjects’ bladders were expressed in the morning (8–9:30 a.m.) and evening
(6–7:30 p.m.) until they regained bladder control, which was defined operationally as
having an empty bladder, with no more than a few drops of urine, at both times of
expression for three consecutive days. All treatments and testing occurred between 10
a.m. and 5 p.m.
The institutional animal care committee at Texas A&M University reviewed and
approved all of the experimental protocols, which follow all NIH guidelines for the care
and use of animal subjects.
5Surgery
Rats received a contusion injury with the MASCIS device developed by Bruner
(1992) and Constantini and Young (1994). Each subject was first anesthetized with
pentobarbital (50 mg/kg, i.p.) to reach a stable, comparable level of anesthesia, as
verified by assessment of spinal reflexes. An area extending approximately 4.5 cm
rostral and caudal to the site of injury was shaved and disinfected with iodine. Subjects’
eyes were spread with petroleum jelly to maintain moisture in the absence of blinking. A
7.0-cm incision was made over the vertebral column, and an incision was made on each
side of the vertebral column, extending approximately 3.0 cm rostral and caudal to the
T10–T11 (thoracic vertebrae 10–11) segment. Next the vertebrae dorsal and medial to
T10–T11 were cleared to expose the spinal tissue. The vertebral column was secured
with the MASCIS device, and the 10-g impactor with 3-mm tip was dropped 12.5 mm to
produce a moderate injury. The subject was then removed from the MASCIS device and
placed on a heating pad, and its wound was closed with Michel clips. Subjects remained
in a recovery room maintained at 26.6° C for 24 hrs after surgery (while they could not
reliably maintain their own body temperature) and were treated with 100,000 units/kg
Pfizerpen (penicillin G potassium) after 2 days (to prevent infection). Michel clips were
removed 14 days after surgery.
Apparatus
Twenty-four hours after surgery, subjects received MK-801 [(5R,10S)-(+)-5-
methyl-10,11-dihydro-5H-dibenzo[a,d]cyclo-hepten-5,10-imine hydrogen maleate;
6Sigma-Aldrich, Inc.; 0.08 mg/kg, i.p.] or its vehicle. These doses have been shown to be
effective in other paradigms (Keith & Rudy, 1990; Gallagher, 1990). After 30 min, half
the subjects in each drug condition received 6 min of uncontrollable (noncontingent),
intermittent tail shock. Rats were loosely restrained in Plexiglas tubes (22 [length] x 6.8
[internal diameter] cm) with 5.5-cm wide platforms inside (lying 5.3 cm from the top of
the tube), Plexiglas covering the rostral end of the tube, and holes drilled for ventilation.
A 660-V AC transformer and 2.03-Mohm series resistor together delivered a constant-
current shock to the tail through cutaneous shock electrodes constructed from modified
fuse clips, lightly coated with electrode paste and attached with adhesive tape 15 cm
from the base of the subject’s tail (for additional details, see Crown et al., 2002).
Because the spinal cord was injured, neural transmission to the brain was disrupted. This
minimized the degree to which subjects “experienced” pain during stimulation. The
remaining rats were treated the in the same manner but with the series disconnected so
that they did not receive shock.
Locomotor Testing
Locomotor recovery was monitored over the next 3 weeks. Hindlimb locomotor
performance was evaluated with the procedure and apparatus described by Basso and
colleagues (1995). Prior to surgery, subjects were acclimated to transport, handling, and
the open field apparatus (a 99.1 [diameter] x 20.3 [depth] cm blue children’s wading
pool), 4 min/day for 3 days because rodents often remain motionless on their first
introduction to an apparatus. During testing, subjects were observed in a circular plastic
7observation chamber for 4 minutes by experimenters blind to the treatment condition and
tested for high intra- and inter-observer reliability. Intermediate milestones of the 0–21
scoring scale used include: slight movement of one joint (1), extensive (>50%)
movement of all three joints (ankle, knee, and hip) (7), occasional (1–50%) weight-
supported plantar stepping without forelimb-hindlimb (FL-HL) coordination (10), and
consistent (95–100%) weight-supported plantar stepping with consistent FL-HL
coordination (14).
The first observation was performed 24 hours after surgery, Day 1, before drug
and shock treatment. Subsequent observations occurred on Days 2, 3, 4, 5, 6, 7, 9, 11,
13, 15, 18, and 21, along with weighing.
Behavioral Testing
At the end of the 21-day locomotor testing period, subjects performed three tasks
to evaluate their ability to use their hindlimbs to overcome various obstacles: the ladder
walk, beam walk, and inclined plane.
Acclimation. On Days 19, 20, and 21, the subjects were set on a black wooden
plank (106 [length] x 50 [width] cm) and encouraged to walk across into a black wooden
box (47 [width] x 25.5 [height] x 35.5 [depth] cm), where they were left for 2 min. The
rats exhibit a preference for a dark, enclosed space, so the 2 min spent in the box
motivate them to walk across the plank. This was then repeated twice each day, though
on the last time the rats were not left in the box but were rather removed immediately.
8Ladder walk. On Day 22, the three behavioral tasks were performed. For the
ladder walk, subjects were encouraged to walk across a black wooden ladder (106
[length] x 17 [width] cm, with 0.8-cm diameter rungs with 2.5-cm spaces between them,
totaling 31 rungs). The number of times each leg went down through the rungs of the
ladder, when the subject missed a rung, was counted by one rater on each side.
Beam walk. Then subjects walked across a wooden black beam of 106-cm length,
beginning at 17.2-cm width and ending at 1.0-cm width. Periodic widths are marked on
the side of the apparatus. On each side of the narrowing beam, there is a 1.8-cm step
down to a 3.0-cm area where subjects may step if necessary. As the subjects walk across,
the width of the beam at which they step down is recorded by one rater on each side, and
this is repeated once.
Inclined plane. Subjects were then placed onto an apparatus with an angled
wooden plank covered with horizontally ridged rubber, with thick padding at its bottom
end. The plank was raised to an inclination of 35°, which was increased by 5° until the
subject could no longer stay situated horizontally on the plank for 3 s without sliding
down. Angles were measured and marked on the apparatus beforehand, and were
obtained by propping the plank on a bar with several notches that would catch on a
vertical bar. The test was performed with the subject facing left and then right, and the
highest angle at which the rat could stay standing horizontally, facing each direction,
was recorded.
9Sensory Testing
Within a few days after behavioral testing, tactile reactivity was assessed by
applying von Frey nylon microfilaments (Semmes-Weinstein Anesthesiometer; Stoelting
Co.) to the plantar surface of the paw. Increasingly stiff filaments were applied 2 s apart
until the paw was reflexively withdrawn, revealing the mechanical sensory threshold,
and vocalization occurred, revealing the nociceptive sensory threshold. If one or both
responses were not observed, testing was terminated at a force of 300g. Each subject was
tested twice on each foot in a counterbalanced ABBA order, with test sequences spaced
2 min apart. Stimulus intensity was reported with the formula provided by Semmes-
Weinstein: Intensity = log10(10,000 x g-force).
Within a few days after tactile testing, nociceptive reactivity was further assessed
as described by Grau and colleagues (2004). Radiant heat was applied to the tail, and the
subjects’ latency to exhibit both tail movement and vocalization was measured, not
exceeding 8 s, in order to avoid tissue damage to the subjects’ tail. Constant-current
shock was also administered and was gradually increased, not exceeding 1.2 mA, until
the subject responded.
Histological Analysis
Histological analyses will soon be performed on all subjects to determine the
extent of the damage done to the spinal cord at the area of the contusion injury. Subjects
will be deeply anesthetized (100 mg/kg of pentobarbital, i.p.) and perfused intracardially
with 4% paraformaldehyde. A 1-cm segment of the spinal cord including the lesion
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center will be removed and embedded in paraffin. The tissue will be sectioned coronally
in 20-_m thick sections, and every 18th, 19th, and 20th slice will be preserved for
staining. Sections will be stained with cresyl violet for Nissl substance and luxol fast
blue for myelin (Beattie, 1992; Behrmann, Bresnahan, Beattie, & Shah, 1992). An
experimenter blind to the subject’s treatment condition will make camera lucida
drawings of the sections, tracing around the boundary of the section and boundaries of
cystic formations and areas of dense gliosis (Basso et al., 1996). Nissl-stained areas with
neurons and glia of approximately normal densities denote residual gray matter, and
myelin-stained areas lacking dense gliosis and swollen fibers denote residual white
matter. The images will be scanned onto a Macintosh computer and imported into
CANVAS 8 (Deneba Systems Inc.), where lesion area, area of residual gray matter, area
of residual white matter, and width will be measured. Percent of lesioned tissue in
sections at the lesion center will be compared to that of sections 2.4 mm rostral and
caudal to the lesion center. A correction factor derived from section width will be
applied to control for individual differences.
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RESULTS
The locomotor scores derived from the method of Basso and colleagues (1995)
were transformed as recommended by Ferguson and colleagues (2004) to improve their
metric properties.
Shock treatment impaired locomotor recovery (Fig. 1), and this effect appeared
to be attenuated by MK-801 treatment (Fig. 2).
Fig. 1. Locomotor recovery in saline-treated subjects. A significant effect of shock was observed.
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Fig. 2. Locomotor recovery in MK-801-treated rats. The deleterious effect of shock seems to be
attenuated.
To control for variation in injury level across subjects, the data were analyzed
using an analysis of covariance. The Day 1 score, obtained prior to shock and drug
treatment, served as the covariate. As expected, this factor accounted for a large
proportion of the variance, F(1, 27) = 36.20, p < 0.0001. There was a main effect of
shock treatment, F(1, 27) = 6.93, p < 0.05. The shock x drug interaction approached
significance, F(1, 27) = 3.07, p < 0.091. There was also a significant effect of recovery
day, and day x shock treatment interaction, both Fs > 3.14, p < 0.0005. No other term
approached significance, all Fs < 1.0. Planned comparisons revealed that shock had a
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significant effect on recovery in the saline-treated (p < 0.005) but not the MK-801-
treated rats (p > 0.05).
Close inspection of the data from the unshocked controls suggested that MK-801
treatment, per se, had an adverse effect on locomotor performance. This was especially
evident 24 hrs after drug treatment (Fig. 3), F(1, 13) = 5.65, p < 0.05.
Fig. 3. Average Day 2 locomotor performance. The administration of MK-801 was detrimental to
locomotor performance the next day.
MK-801 appeared to have an adverse effect on the recovery of bladder function
(Fig. 4), but this effect did not reach statistical significance, F(1, 27) = 1.20, p > 0.05.
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Fig. 4. Average day of recover of bladder function. MK-801 seemed to adversely affect recovery of
bladder function, though the effect was not significant.
As in prior studies, shock treatment also disrupted recovery of weight after injury
(Fig. 5), and this effect appeared to be attenuated by drug treatment (Fig. 6). The
interaction between shock and drug treatment was marginally significant, F(1, 28) =
3.74, p < 0.06). There was also a significant effect of recovery day, F(12, 336) = 36.71,
p < 0.0001.
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Fig. 5. Weight recovery in saline-treated subjects. Shock treatment disrupted the recovery of weight.
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Fig. 6. Weight recovery in MK-801-treated subjects. MK-801 appeared to attenuate the effect of shock on
weight, though the drug x shock interaction was only marginally significant.
The ladder walk behavioral test showed a marginally significant interaction of
drug and shock treatments, F(1, 27) = 3.79, p < 0.063). The unshocked saline rats and
shocked MK-801 rats seemed to perform better than the shocked saline rats and the
unshocked MK-801 rats. It may seem paradoxical to call their performance better if they
stuck their legs through the rungs a greater number of times. However, at these rats’
level of performance, very low ladder scores indicate that their legs were being held
stationary above the rungs. Higher scores in general characterize rats that were at least
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attempting to use their legs. The implications of the scores would be reversed with
higher-performing rats.
Fig. 7. Average ladder scores. MK-801 appeared to improve ladder scores in shocked rats and worsen
them in unshocked rats.
The other behavioral tests, the beam and the inclined plane, showed no
significant differences between groups (all Fs < 1.884). Tests of tactile and nociceptive
reactivity also showed no significant differences between groups (all Fs < 2.005).
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DISCUSSION
Conclusions
As reported in past studies (Grau et al., 2004), the significant effect of shock
treatment indicates that uncontrollable stimulation impairs recovery after spinal cord
injury. My results suggest that the adverse effect of uncontrollable stimulation can be
attenuated by the NMDA receptor antagonist MK-801.
 Unexpectedly, MK-801 alone can adversely affect locomotor performance after
the drug has cleared the system. This effect was especially evident in the Day 2 scores,
which dipped for shocked groups and MK-801 groups, but not for the unshocked saline
group. MK-801 groups also seemed to be impaired in regaining bladder function.
However, MK-801 seemed to protect rats from the adverse effects of shock on weight
gain, though this effect was only marginally significant and was obscured by the
difference in initial weight across groups.
Further Inquiry
I am now examining a lower dose of MK-801, 0.02 mg/kg, to determine if it may
have a protective effect from uncontrollable stimulation without causing damage per se.
Preliminary results are promising, as this dose does not cause a dip in Day 2 scores in
unshocked subjects.
Implications
A precise statement about the clinical significance of MK-801 in improving the
long-term outcome of spinal cord injury cannot be made yet. There is evidence that MK-
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801 protects the contused spinal cord from the adverse effects of uncontrollable
stimulation, but it is important to discern that there is a dose of MK-801 that has this
protective effect without its own adverse effect.
This study fits within an array of experiments with animal and human models
examining the benefits of NMDA receptor antagonists in suppressing central
sensitization.
Faden and Simon showed in 1988 that NMDA worsened the outcome of thoracic
spinal cord injury in rats. NMDA’s stereoisomer, NMLA, had no effect, and MK-801
improved the outcome. Faden, Ellison, and Noble (1990) found that the administration
of the non-competitive NMDA receptor antagonist CPP or the competitive NMDA
receptor antagonist dextrorphan also improved the outcome of thoracic spinal cord
injury. Yum and Faden (1990) showed that MK-801 protected nervous tissue from
secondary damage caused by ischemic central nervous system injury, which is injury
involving blood restriction to the nervous system. Searching for factors that play a role
in the adverse effects of NMDA receptors on spinal cord injury, Yanasse, Sakou, and
Fukuda (1995) indicated that NMDA receptors contribute to edema formation in the
early stages after spinal cord injury. They too showed that MK-801 administration after
spinal cord injury significantly improved motor recovery. They found that MK-801
reduced edema formation at the site of injury but did not alter blood flow or vascular
permeability. Li and Tator (2000) concurred that MK-801 did not protect the spinal cord
by altering blood flow. Wada and colleagues (1999) clarified that the NMDA receptor
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promotes delayed cell death of neurons and glia through apoptosis. They found that the
spinal cords rats treated with MK-801 after spinal cord injury exhibited significantly less
apoptosis than those of rats treated with saline after injury. Evidence against the
potential of NMDA receptor antagonists came from Haghighi and colleagues (2000),
who did not find a significant effect of MK-801 administration on rats given spinal cord
injuries. However, Haghighi, Johnson, de Vergel, and Vergel Rivas (1996) showed that
pretreatment with MK-801 improved the neurophysiological outcome of rats that
received spinal cord injuries. Overall, despite somewhat mixed results in various
contexts, clearly animal models have demonstrated the adverse effects of NMDA
receptors on subjects given spinal cord injuries and the potential of NMDA receptor
antagonists in improving the outcome of spinal cord injuries.
Other researchers have searched for more-effective NDMA receptor antagonists.
The recently developed noncompetitive NMDA receptor antagonist gacyclidine has
received favorable assessment (Feldblum, Arnaud, Simon, Rabin, & D’Arbigny, 2000;
Gaviria et al., 2000).Yu, Marcillo, Fairbanks, Wilcox, and Yezierski (2000) promote the
use of agmatine, an NMDA receptor antagonist and nitric oxide synthase (NOS)
inhibitor. NOS contributes to secondary damage after spinal cord injury. They found that
agmatine significantly improved locomotor recovery and reduced tissue damage in rats
given spinal cord injuries. They went on to emphasize the importance of drugs with
multiple targets for treatment following spinal cord injury.
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Clinical studies have provided evidence that NMDA receptor antagonists can
reduce the effects of central sensitization in humans. Patients with central dysesthesia
pain, which is centrally mediated burning pain, experienced less pain when treated with
ketamine, another noncompetitive NMDA receptor antagonist (Eide, Stubhaug, &
Stenehjem, 1995). The subjects did not experience significant side effects. Ketamine
also significantly reduced post-herpetic neuralgia after intravenous administration
compared to both saline and morphine (Eide, Jørum, Stubhaug, Bremnes, & Breivik,
1994).
Ketamine has also been shown to inhibit secondary hyperalgesia if given to
subjects during and after surgery (Stubhaug, Breivik, Eide, Kreunen, & Foss, 1997). The
kidney donors who received ketamine not only showed lower punctuate mechanical
hyperalgesia measured with von Frey filaments than did donors who received placebo,
but also consumed less morphine after surgery and reported higher global satisfaction.
The authors attribute this to ketamine’s blocking the induction of central sensitization.
Therefore, it appears that NMDA receptor antagonists already show promising
results in treating neuropathic pain in humans. It is theorized that this type of pain is
caused by central sensitization, which has also been implicated in causing secondary
nervous system damage and poor locomotor recovery in animal models. My study
incorporates the important factor of uncontrollable nociceptive stimulation,
demonstrating that MK-801 can protect spinally injured rats from its adverse effects. In
human spinal cord injury, uncontrollable nociceptive stimulation is often an issue
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because of associated peripheral injuries. There are even clinical treatments intended to
improve motor function following spinal cord injury that entail application of
uncontrollable stimulation to a limb to prevent muscle atrophy. In both of these cases,
the patient may not experience pain because of damaged spinal cord connections, but the
stimulation could cause secondary damage to the spinal cord. An NMDA receptor
antagonist could protect the patient’s spinal cord from this secondary damage. This study
therefore adds an important dimension to the research on the protective effects of
NMDA receptor antagonists following spinal cord injury and expands their potential
clinical implications. Furthermore, it illustrates the necessity to exercise caution in
administering an NMDA receptor antagonist in clinical studies, because a high dose can
cause secondary damage on its own.
23
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